Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06407388 · ClinicalTrials.gov registry record

Ultrasound Findings in Diabetic Pregnancies

A clinical trial of Diabetes, sponsored by Eastern Virginia Medical School.

Recruiting
Registry status
156
Enrollment target
1
Study location

NCT06407388 is a study of Diabetes that is actively recruiting participants, run by Eastern Virginia Medical School. The registered enrollment target is 156 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06407388, a study of Diabetes, is actively recruiting participants, sponsored by Eastern Virginia Medical School.

RECRUITING
Registry status
156 participants
Enrollment target
1
Study location

Study Summary

The goal of our study is to identify ultrasonographic markers that can predict adverse neonatal outcomes. Specifically, we hypothesize that an increase in fetal liver volumes will increase transcutaneous bilirubin (TcB) in the newborn and thus jaundice requiring phototherapy. This information can be used in patient counseling and to guide future screening protocols for ultrasound in individuals with diabetes.

Conditions Studied

Study Locations (1)

Virginia

  • Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Eastern Virginia Medical School - Norfolk

Trial Details

FieldValue
Enrollment Target 156 participants
Start Date 2023-06-01
Est. Completion 2025-06-01

Sponsor

Eastern Virginia Medical School

36 total trials

What the Registry Record Tells You About NCT06407388

The ClinicalTrials.gov registry entry for NCT06407388 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 156 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (95% lower). The listed sponsor is Eastern Virginia Medical School, which has 36 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes appearing as the primary indexed condition, and to 0 interventions.

NCT06407388 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.

Frequently Asked Questions

What is clinical trial NCT06407388 about?

NCT06407388 is a clinical study titled "Ultrasound Findings in Diabetic Pregnancies". The goal of our study is to identify ultrasonographic markers that can predict adverse neonatal outcomes. Specifically, we hypothesize that an increase in fetal liver volumes will increase transcutaneous bilirubin (TcB) in the newborn and thus jaundice requiring phototherapy. This information can be...

What is the current status of trial NCT06407388?

This trial is currently recruiting. The enrollment target is 156 participants. The study started on 2023-06-01. Estimated completion is 2025-06-01.

What conditions does trial NCT06407388 study?

This clinical trial studies the following conditions: Diabetes.

Who is sponsoring clinical trial NCT06407388?

This trial is sponsored by Eastern Virginia Medical School, which has 36 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06407388 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.